Literature DB >> 7488097

Gamma-glutamylcysteine synthetase gene overexpression results in increased activity of the ATP-dependent glutathione S-conjugate export pump and cisplatin resistance.

H Kurokawa1, T Ishida, K Nishio, H Arioka, M Sata, H Fukumoto, M Miura, N Saijo.   

Abstract

The ATP-dependent glutathione S-conjugate export pump (GS-X pump) has been suggested to play a role in the mechanism of cisplatin resistance. The purpose of this study was to determine the relationship between intracellular glutathione (GSH) levels and GS-X pump activity and whether GS-X pump overexpression results in cisplatin resistance. We transfected the human gamma-glutamylcysteine synthetase (gamma-GCS) gene into a human small-cell lung cancer cell line, SBC-3, producing SBC-3/GCS. The intracellular GSH content of SBC-3/GCS was twice that of the parental line, its GS-X pump activity was significantly enhanced and cellular cisplatin accumulation decreased. SBC-3/GCS showed higher resistance (relative resistance value of 7.4) to cisplatin than the parental line SBC-3. These data indicate that gamma-GCS gene overexpression induces cellular cisplatin resistance associated with increases in both the GSH content and GS-X pump activity, resulting in reduced cisplatin accumulation. In conclusion, GS-X pump expression is related to cellular GSH metabolism and involved in cisplatin resistance.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7488097     DOI: 10.1006/bbrc.1995.2618

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Overexpression of the regulatory subunit of gamma-glutamylcysteine synthetase in HeLa cells increases gamma-glutamylcysteine synthetase activity and confers drug resistance.

Authors:  S R Tipnis; D G Blake; A G Shepherd; L I McLellan
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

2.  Utilization of arsenic trioxide as a treatment of cisplatin-resistant non-small cell lung cancer PC-9/CDDP and PC-14/CDDP cells.

Authors:  Toshihiro Suzuki; Kenichi Ishibashi; Atsushi Yumoto; Kazuto Nishio; Yuki Ogasawara
Journal:  Oncol Lett       Date:  2015-06-10       Impact factor: 2.967

3.  Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals.

Authors:  Seiko Ishida; Jaekwon Lee; Dennis J Thiele; Ira Herskowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-07       Impact factor: 11.205

4.  Regulation of human gamma-glutamylcysteine synthetase: co-ordinate induction of the catalytic and regulatory subunits in HepG2 cells.

Authors:  D C Galloway; D G Blake; A G Shepherd; L I McLellan
Journal:  Biochem J       Date:  1997-11-15       Impact factor: 3.857

5.  Glutathione-Scavenging Poly(disulfide amide) Nanoparticles for the Effective Delivery of Pt(IV) Prodrugs and Reversal of Cisplatin Resistance.

Authors:  Xiang Ling; Xing Chen; Imogen A Riddell; Wei Tao; Junqing Wang; Geoffrey Hollett; Stephen J Lippard; Omid C Farokhzad; Jinjun Shi; Jun Wu
Journal:  Nano Lett       Date:  2018-06-19       Impact factor: 11.189

Review 6.  Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer.

Authors:  David J Stewart
Journal:  Crit Rev Oncol Hematol       Date:  2010-01-04       Impact factor: 6.312

7.  Manipulation of cellular GSH biosynthetic capacity via TAT-mediated protein transduction of wild-type or a dominant-negative mutant of glutamate cysteine ligase alters cell sensitivity to oxidant-induced cytotoxicity.

Authors:  Donald S Backos; Chad N Brocker; Christopher C Franklin
Journal:  Toxicol Appl Pharmacol       Date:  2009-11-13       Impact factor: 4.219

8.  Role of glutathione, glutathione S-transferases and multidrug resistance-related proteins in cisplatin sensitivity of head and neck cancer cell lines.

Authors:  M J Welters; A M Fichtinger-Schepman; R A Baan; M J Flens; R J Scheper; B J Braakhuis
Journal:  Br J Cancer       Date:  1998-02       Impact factor: 7.640

9.  Expression of gamma-glutamylcysteine synthetase (gamma-GCS) and multidrug resistance-associated protein (MRP), but not human canalicular multispecific organic anion transporter (cMOAT), genes correlates with exposure of human lung cancers to platinum drugs.

Authors:  T Oguri; Y Fujiwara; T Isobe; O Katoh; H Watanabe; M Yamakido
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

Review 10.  Highlights for ESMO 40: celebration review for lifetime achievement awards.

Authors:  Nagahiro Saijo
Journal:  ESMO Open       Date:  2016-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.